Oramed Pharmaceuticals Inc (ORMP)
2.305
-0.02
(-1.07%)
USD |
NASDAQ |
May 17, 16:00
2.305
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals 1 Year Total Returns (Daily): -40.10% for May 16, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 16, 2024 | -40.10% |
May 15, 2024 | -23.64% |
May 14, 2024 | -12.72% |
May 13, 2024 | -14.84% |
May 10, 2024 | -17.41% |
May 09, 2024 | -18.77% |
May 08, 2024 | -19.80% |
May 07, 2024 | -13.67% |
May 06, 2024 | -10.43% |
May 03, 2024 | -15.16% |
May 02, 2024 | -10.34% |
May 01, 2024 | -4.49% |
April 30, 2024 | 2.20% |
April 29, 2024 | 7.27% |
April 26, 2024 | 10.31% |
April 25, 2024 | 5.02% |
April 24, 2024 | 4.41% |
April 23, 2024 | 2.17% |
April 22, 2024 | 1.30% |
April 19, 2024 | -0.44% |
April 18, 2024 | -3.08% |
April 17, 2024 | 2.19% |
April 16, 2024 | 7.14% |
April 15, 2024 | 8.04% |
April 12, 2024 | 15.07% |
Date | Value |
---|---|
April 11, 2024 | 19.44% |
April 10, 2024 | 23.72% |
April 09, 2024 | 23.96% |
April 08, 2024 | 27.65% |
April 05, 2024 | 23.11% |
April 04, 2024 | 20.83% |
April 03, 2024 | 24.43% |
April 02, 2024 | 28.44% |
April 01, 2024 | 29.82% |
March 28, 2024 | 34.56% |
March 27, 2024 | 30.56% |
March 26, 2024 | 26.51% |
March 25, 2024 | 28.37% |
March 22, 2024 | 34.72% |
March 21, 2024 | 26.13% |
March 20, 2024 | 35.16% |
March 19, 2024 | 26.91% |
March 18, 2024 | 26.01% |
March 15, 2024 | 44.55% |
March 14, 2024 | 28.23% |
March 13, 2024 | 37.81% |
March 12, 2024 | 46.67% |
March 11, 2024 | 50.77% |
March 08, 2024 | 36.07% |
March 07, 2024 | 31.19% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-82.49%
Minimum
Feb 10 2023
1.01K%
Maximum
Nov 15 2021
49.58%
Average
-15.18%
Median
1 Year Total Returns (Daily) Benchmarks
ACADIA Pharmaceuticals Inc | -32.13% |
Cassava Sciences Inc | -14.72% |
Vertex Pharmaceuticals Inc | 27.67% |
Cormedix Inc | 16.59% |
Oragenics Inc | -43.06% |